GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (OTCPK:CHSYF) » Definitions » Equity-to-Asset

China Medical System Holdings (China Medical System Holdings) Equity-to-Asset : 0.88 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is China Medical System Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. China Medical System Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2,174 Mil. China Medical System Holdings's Total Assets for the quarter that ended in Dec. 2023 was $2,483 Mil. Therefore, China Medical System Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.88.

The historical rank and industry rank for China Medical System Holdings's Equity-to-Asset or its related term are showing as below:

CHSYF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.63   Med: 0.82   Max: 0.88
Current: 0.88

During the past 13 years, the highest Equity to Asset Ratio of China Medical System Holdings was 0.88. The lowest was 0.63. And the median was 0.82.

CHSYF's Equity-to-Asset is ranked better than
92.1% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs CHSYF: 0.88

China Medical System Holdings Equity-to-Asset Historical Data

The historical data trend for China Medical System Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings Equity-to-Asset Chart

China Medical System Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 0.87 0.81 0.82 0.88

China Medical System Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.81 0.82 0.87 0.88

Competitive Comparison of China Medical System Holdings's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical System Holdings's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where China Medical System Holdings's Equity-to-Asset falls into.



China Medical System Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

China Medical System Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2173.638/2483.241
=0.88

China Medical System Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2173.638/2483.241
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical System Holdings  (OTCPK:CHSYF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


China Medical System Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of China Medical System Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


China Medical System Holdings (China Medical System Holdings) Business Description

Traded in Other Exchanges
Address
510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.

China Medical System Holdings (China Medical System Holdings) Headlines